Linac based repeat srs dose

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.

Mandelin Rain

Full Member
10+ Year Member
Joined
Apr 21, 2011
Messages
3,171
Reaction score
7,860

Members don't see this ad.
1 progressive lesion of many treated melanoma mets. Previous dose 20Gy in 1 fx a year ago. 1.5 cm now with moderate vasogenic edema.

Thinking of fractionated approach. 6Gy x 5 or 9 Gy x 3. Any consensus?
 

Neuronix

Total nerd
Staff member
Administrator
Volunteer Staff
20+ Year Member
Joined
Mar 14, 2002
Messages
14,609
Reaction score
7,532
1 progressive lesion of many treated melanoma mets. Previous dose 20Gy in 1 fx a year ago. 1.5 cm now with moderate vasogenic edema.

Thinking of fractionated approach. 6Gy x 5 or 9 Gy x 3. Any consensus?

No consensus. My first choice would be surgery to confirm growth of disease as opposed to RT necrosis. If you're convinced or resection is not feasible I would do 6 Gy x 5.
 
  • Like
Reactions: 2 users

Mandelin Rain

Full Member
10+ Year Member
Joined
Apr 21, 2011
Messages
3,171
Reaction score
7,860
Spect MRI most consistent with tumor. Patient obviously doesn't want surgery (who does?).
 

OTN

Member
15+ Year Member
Joined
Nov 6, 2003
Messages
2,112
Reaction score
5,826
Surgery first, if pt refuses, then 6 Gy x 5 is what I would do
 
  • Like
Reactions: 1 users

evilbooyaa

Full Member
Staff member
Volunteer Staff
10+ Year Member
Joined
Oct 10, 2011
Messages
8,040
Reaction score
9,401
Wake forest has some toxicity data on re-treatment:


Plan for say 18x1, evaluating minimization of composite V40 with previous treatment, then after plan is completed, change prescription to 9x3 would be my go-to.
 

Lamount

Full Member
10+ Year Member
Joined
Mar 21, 2012
Messages
1,310
Reaction score
2,463
At a few places that I have worked, we had NSG use LITT in these circumstances... with the added benefit of obtaining a biopsy to determine necrosis vs. recurrence.
 
  • Like
Reactions: 1 user

BobbyHeenan

Full Member
10+ Year Member
Joined
Mar 20, 2013
Messages
1,596
Reaction score
2,721
This clinical case is becoming more common. I swear pre immunotherapy I never saw this. Everyone died a year later.


All I can say is get the bevacizumab ready. Works like a charm when you’re scratching your head on necrosis vs progression 3 months later.
 
  • Like
Reactions: 1 users

evilbooyaa

Full Member
Staff member
Volunteer Staff
10+ Year Member
Joined
Oct 10, 2011
Messages
8,040
Reaction score
9,401
This clinical case is becoming more common. I swear pre immunotherapy I never saw this. Everyone died a year later.


All I can say is get the bevacizumab ready. Works like a charm when you’re scratching your head on necrosis vs progression 3 months later.

Had one patient with steroid-refractory necrosis (like 8mg BID kept her symptoms in check but couldn't wean her off at all), who refused surgery (as she'd already had at least 2-3 resections) and finally convinced a med-onc to give the Avastin. The low-dose Avastin worked like a charm. Wish it wasn't so painful to convince med-onc/neuro-onc to give it.
 
  • Like
Reactions: 1 users

radoncgrad2019

Membership Revoked
Removed
Joined
Jun 18, 2019
Messages
475
Reaction score
416
It depends where you are. Med oncs are happy to give it for necrosis in my experience
 
  • Like
Reactions: 1 user

Mandelin Rain

Full Member
10+ Year Member
Joined
Apr 21, 2011
Messages
3,171
Reaction score
7,860
The discussion of necrosis as a foregone conclusion has me bummed.
 

evilbooyaa

Full Member
Staff member
Volunteer Staff
10+ Year Member
Joined
Oct 10, 2011
Messages
8,040
Reaction score
9,401
I mean it's not 100% but probably closer to 20-30%, which is not nothing.

Sorry to clarify - I mean the risk of necrosis after you re-treat this. Melanoma brain mets not having 100% success rate to SRS is not unexpected.

If you're not convinced it's necrosis now, then reasonable IMO to re-treat.
 
Last edited:
  • Like
Reactions: 1 user
Top